Dawn Carter Bir

Dawn Carter Bir

DirectoratGeron· In proxies 2023–2025

Pay in FY2025Geron stock -62.7% the same year

Dawn Carter Bir was paid $522.1K in FY2025 (Dec). Geron stock fell 62.7% that year.

Pay$100 in the stock at the end of FY24 → $37
Pay is from the Summary Compensation Table of each Geron proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Filana TherapeuticsPublic company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years
  2. GeronPublic company · 3 yr
    • Former Interim President and Chief Executive Officer (as of March 17, 2025)2023 – Present · 3 yrStock in role -53%
  3. Cassava Sciences, Inc.Public company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years
  4. Soleno Therapeutics, Inc.Public company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • Filana TherapeuticsDirector · 0 yr on the boardIndependent—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?